Afterwards, the multivariable model suggested that CDC42 at D7 (high vs. low) (HR: 0.295, P = 0.023) and HDL-C (high vs. low) (HR: 0.150, P = 0.004) were independently correlated with a lower MACE rate, but family history of CAD (yes vs. no) (HR: 3.783, P = 0.014), multivessel disease (yes vs. no) (HR: 4.628, P = 0.020), and CRP (high vs. low) (HR: 4.276, P = 0.029) were independently linked with a higher MACE rate in DCB-treated SV-CAD patients (Table 5). This evidence concerns the gene CRP and glycogen storage disease VI.